From Queens to Manhattan, these restaurants are setting the pace for the year ahead.

It's officially love month and these Valentine's Day dining experiences across Mumbai, Pune, Bengaluru, Goa and Hyderabad are ready to set the mood ...

Some restaurants are worth putting miles on your odometer, and Jimmy’s Steer House in Arlington, Massachusetts is exactly that kind of destination – a place where carnivores make pilgrimages for beef ...

Brazilian guitarist Lucas Imbiriba, playing as part of International Guitar Night, combines flamenco and classical influences with Latin American rhythms and the power of rock. Thereza Maciel Courtesy ...

As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage drugs, including a gene therapy from its $1 billion acquisition of Prevail ...

Eli Lilly and Co. reported fourth-quarter results Wednesday that topped Wall Street expectations, with revenue of $19.3 billion — up 43% from the same quarter a year ago, driven by growth in sales of ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Eli Lilly beat analysts’ revenue expectations by 9.7% last ...

After launching in 2006, The Oaks Lily is celebrating its 20th anniversary this year and is known as the official cocktail of the Kentucky Oaks.

Eli Lilly & Co. provided an upbeat sales forecast for the year Wednesday as strong demand for its weight loss drug cemented its position at the top of the obesity market. The guidance was a sharp ...

Eli Lilly has leading products in the GLP-1 space, with plans to bring pill versions of its weight loss shots to market. Pfizer is playing catch-up in the GLP-1 space, but it has a long history of ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q4 CY2025 results exceeding the market’s revenue expectations , with sales up 42.6% year on year to $19.29 billion. The company’s full-year ...